Complicated Osteoporosis in Progeroid Syndrome: Treatment With Teriparatide

被引：0
作者：
Iglesias Bolanos, Paloma [1 ]
Guijarro de Armas, Guadalupe [1 ]
Civantos Modino, Soraya [1 ]
Vega Pinero, Belen [1 ]
Pavon de Paz, Isabel [1 ]
Monereo Megias, Susana [1 ]
机构：
[1] Getafe Univ Hosp, Dept Endocrinol, Madrid 28007, Spain
来源：
JOURNAL OF CLINICAL DENSITOMETRY | 2012年 / 15卷 / 01期
关键词：
Fracture; osteoporosis; progeroid syndrome; teriparatide; MODEL;
D O I：
10.1016/j.jocd.2011.10.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Human progeroid syndromes (PSs) include a group of genetic "premature aging" diseases that affect a variety of organ systems. Bone diseases are common sequelae of patients diagnosed with PSs. Teriparatide therapy is recommended for elderly men with low bone mineral density (BMD; T-score < -2.5) and at least 1 fragility fracture who are unable to tolerate bisphosphonates. We describe a 20-yr-old patient affected by PS and severe osteoporosis complicated with femoral fracture. The patient experienced a significant improvement in lumbar spine BMD after treatment with teriparatide.
引用
收藏
页码：116 / 119
页数：4
相关论文
共 50 条
  • [21] Treatment with teriparatide in a patient with pregnancy-associated osteoporosis
    Hellmeyer, Lars
    Boekhoff, Jelena
    Hadji, Peyman
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2010, 26 (10) : 725 - 728
  • [22] Contributors to Secondary Osteoporosis in Patients Referred for Treatment with Teriparatide
    Anaforoglu, Inan
    Asik, Mehmet
    Ersoy, Kerem
    Kose, Mustafa
    Ayhan, Semiha
    Algun, Ekrem
    [J]. TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2013, 17 (04) : 98 - 101
  • [23] Hypomagnesemia During Teriparatide Treatment in Osteoporosis: Incidence and Determinants
    Begin, Marie-Josee
    Ste-Marie, Louis-Georges
    Coupal, Louis
    Ethier, Jean
    Rakel, Agnes
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (08) : 1444 - 1449
  • [24] Teriparatide for osteoporosis: importance of the full course
    Lindsay, R.
    Krege, J. H.
    Marin, F.
    Jin, L.
    Stepan, J. J.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2016, 27 (08) : 2395 - 2410
  • [25] Teriparatide for osteoporosis: importance of the full course
    R. Lindsay
    J. H. Krege
    F. Marin
    L. Jin
    J. J. Stepan
    [J]. Osteoporosis International, 2016, 27 : 2395 - 2410
  • [26] Analyzing the factors associated with efficacy among teriparatide treatment in postmenopausal women with osteoporosis
    Kong, Meng
    Gao, Changtong
    Luan, Xiaona
    Fan, Cuiying
    Hao, Meng
    Jin, Canghai
    Zhao, Jiangning
    Li, Hongyan
    Zhao, Jindong
    Luan, Jian
    Lin, Yong
    Li, Qiang
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2024, 25 (01)
  • [27] Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis
    M. M. Bonafede
    N. Shi
    A. G. Bower
    R. L. Barron
    A. Grauer
    D. B. Chandler
    [J]. Osteoporosis International, 2015, 26 : 1203 - 1212
  • [28] Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy
    Nasomyont, N.
    Keefe, C.
    Tian, C.
    Hornung, L.
    Khoury, J.
    Tilden, J. C.
    Hochwalt, P.
    Jackson, E.
    Rybalsky, I
    Wong, B. L.
    Rutter, Meilan M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2020, 31 (12) : 2449 - 2459
  • [29] Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy
    N. Nasomyont
    C. Keefe
    C. Tian
    L. Hornung
    J. Khoury
    J. C. Tilden
    P. Hochwalt
    E. Jackson
    I. Rybalsky
    B. L. Wong
    M. M. Rutter
    [J]. Osteoporosis International, 2020, 31 : 2449 - 2459
  • [30] Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis
    Bonafede, M. M.
    Shi, N.
    Bower, A. G.
    Barron, R. L.
    Grauer, A.
    Chandler, D. B.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2015, 26 (03) : 1203 - 1212
12345